一、中文名称：Recombinant Human SLC34A2/NaPi2b Protein, N-GST蛋白抗体
二、产品描述
2b型钠依赖性磷酸盐转运体（NaPi-IIb）是一种多通道的膜蛋白，由690个氨基酸组成，是溶质载体SLC34家族的成员，该家族由NaPi-IIa（SLC34A1）、NaPi-IIb（SLC34A2）和NaPi-IIc（SLC34A3）构成。其中NaPi-IIb蛋白通过钠离子共转运介导无机磷酸盐进入上皮细胞，负责维持全身的磷酸盐平衡。NaPi-IIb包含两个保守序列的倒置重复单元，由一个大的细胞外环连接，两个末端都位于细胞膜内。NaPi-IIb是由基因SLC34A2编码而来，SLC34A2的cDNA于1999年首次从人类小肠和肺部cDNA文库中分离并克隆出来，虽然SLC34A2在人类的各种组织中都有表达，但在肺、小肠和肾脏中的表达量最高。最近的研究发现SLC34A2的表达在NSCLC的手术样本和正常组织之间有明显的差异，并且SLC34A2在肺腺癌细胞系A549中下调，上调SLC34A2的表达可以明显抑制A549的细胞活力和体外侵袭。这些结果表明，SLC34A2可能在NSCLC的发展中发挥重要作用。除肺癌外，SLC34A2主要影响的另一疾病就是卵巢癌，其在大部分上皮性卵巢癌中过表达。此外，SLC34A2的异常表达还与肺泡微石症（PAM）、低磷血症、不孕症、睾丸微石症（TM）和其他恶性肿瘤（包括甲状腺癌、乳腺癌等）有关。
三、产品详情
名称：Recombinant Human SLC34A2/NaPi2b Protein, N-GST (YHB65402)
别名：Sodium/phosphate cotransporter 2B, Na(+)-dependent phosphate cotransporter 2B, Na(+)/Pi cotransporter 2B, Sodium-dependent phosphate transport protein 2B, NaPi3b, NaPi-2b,NaPi2b,SLC34A2, Solute carrier family 34 member 2, Sodium-phosphate transport protein 2B
货号：YHB65402
表达系统：E. coli
种属：Homo sapiens (Human)
蛋白长度：Asn189-Leu362
预测分子量：46.33 kDa
性质：Recombinant
内毒素水平：Please contact with the lab for this information.
纯度：>90% as determined by SDS-PAGE.
Accession号：O95436
应用：ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
状态：Lyophilized
保存溶液：Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
重悬：Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
运输：In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
稳定性和存储：Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
四、参考文献：
SLC34A2 promotes cancer proliferation and cell cycle progression by targeting TMPRSS3 in colorectal cancer. PMID: 34929599
The role of SLC34A2 in intestinal phosphate absorption and phosphate homeostasis. PMID: 30343332
Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma. PMID: 30592329
Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases. PMID: 34944522
SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. PMID: 32005974
The SLC34A2-ROS-HIF-1-induced up-regulation of EZH2 expression promotes proliferation and chemo-resistance to apoptosis in colorectal cancer. PMID: 30038060
New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review. PMID: 37259144
SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures. PMID: 23164546
Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis. PMID: 35443721
SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3beta-mediated activation of Wnt/beta-catenin signaling. PMID: 30868061
SLC34A2 promotes cell proliferation by activating STX17-mediated autophagy in esophageal squamous cell carcinoma. PMID: 38720472
SLC34A2 Targets in Calcium/Phosphorus Homeostasis of Mammary Gland and Involvement in Development of Clinical Mastitis in Dairy Cows. PMID: 38731279
Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion. PMID: 28281971
Constitutive depletion of Slc34a2/NaPi-IIb in rats causes perinatal mortality. PMID: 33846411
SLC34A2 regulates miR-25-Gsk3beta signaling pathway to affect tumor progression in gastric cancer stem cell-like cells. PMID: 29178392
Is SLC34A2 Associated With Concomitant Calcium Metabolism Disorder in Pulmonary Alveolar Microlithiasis (PAM)? PMID: 37217383
NaPi2b expression in a large surgical Non-Small Cell Lung Cancer (NSCLC) cohort. PMID: 34953676
Antibody-Drug Conjugates in Gynecologic Cancer. PMID: 37229642
(213)Bi/(211)At-Labeled MX35, an anti-sodium-dependent phosphate transport protein 2b (NaPi2b) murine monoclonal antibody. PMID: 22675742
Toward a Topology-Based Therapeutic Design of Membrane Proteins: Validation of NaPi2b Topology in Live Ovarian Cancer Cells. PMID: 35911971
Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer. PMID: 34504954
Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b). PMID: 35917765
Design, synthesis and biological evaluation of novel pyridine derivatives as gut-selective NaPi2b inhibitors. PMID: 35346844
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. PMID: 30158152
Discovery of Gut-Restricted Small-Molecule Inhibitors of Intestinal Sodium-Dependent Phosphate Transport Protein 2b (NaPi2b) for the Treatment of Hyperphosphatemia. PMID: 35034442
Development of monoclonal antibodies specific for the human sodium-dependent phosphate co-transporter NaPi2b. PMID: 18724815
详情请咨询Antibodysystem中国授权总代理-武汉佰乐博生物技术有限公司
网址：https://www.antibodysystem.com/product/11408.html
武汉佰乐博生物技术有限公司作为法国Antibodysystem品牌亚洲区授权总代理。提供近3万种蛋白、抗体等核心生命科学试剂，旨在为生命科学科研工作者提供专业、全面、可靠的试剂产品。
试剂 | 耗材 | 定制 | 实验服务 | 供应链
免费热线：027-65279366 /18108604356
